Publicaciones (85) Publicaciones de MARÍA ÁNGELES VICENTE LÓPEZ

2024

  1. Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study

    Experimental Dermatology, Vol. 33, Núm. 8

2023

  1. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa

    British Journal of Dermatology, Vol. 189, Núm. 6, pp. 774-776

2022

  1. Acute lymphoblastic leukemia cells are able to infiltrate the brain subventricular zone stem cell niche and impair neurogenesis

    Haematologica

  2. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes

    Blood, Vol. 139, Núm. 22, pp. 3303-3313

2021

  1. Hif-overexpression and pro-inflammatory priming in human mesenchymal stromal cells improves the healing properties of extracellular vesicles in experimental crohn’s disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 20

2020

  1. Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report

    Frontiers in Medicine, Vol. 7

  2. Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy

    Frontiers in Immunology, Vol. 11

  3. The choroid plexus stroma constitutes a sanctuary for paediatric B-cell precursor acute lymphoblastic leukaemia in the central nervous system

    Journal of Pathology, Vol. 252, Núm. 2, pp. 189-200

2019

  1. Acute lymphoblastic leukaemia cells impair dendritic cell and macrophage differentiation: Role of bmp4

    Cells, Vol. 8, Núm. 7

2017

  1. BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer

    Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399

  2. Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools

    Cytotherapy, Vol. 19, Núm. 5, pp. 640-653

  3. Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells

    Stem Cell Research and Therapy, Vol. 8, Núm. 1

2016

  1. Comparative analysis of the immunomodulatory capacities of human bone marrow– and adipose tissue–derived mesenchymal stromal cells from the same donor

    Cytotherapy, Vol. 18, Núm. 10, pp. 1297-1311

2015

  1. A discrete population of IFN λ-expressing BDCA3 hi dendritic cells is present in human thymus

    Immunology and Cell Biology, Vol. 93, Núm. 7, pp. 673-678

  2. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-aα combination in rheumatoid synoviocytes

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  3. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity

    Cancer Letters, Vol. 363, Núm. 2, pp. 156-165

  4. The BMP pathway participates in human naive CD4+ T cell activation and homeostasis

    PLoS ONE, Vol. 10, Núm. 6

2014

  1. Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells

    European Journal of Immunology, Vol. 44, Núm. 4, pp. 1031-1038

  2. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: Correlations with the course of disease

    PLoS ONE, Vol. 9, Núm. 1

  3. Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling

    Cancer Research, Vol. 74, Núm. 18, pp. 5019-5031